Published in J Neurol Neurosurg Psychiatry on October 01, 1997
Neuropsychiatric symptoms in Parkinson's disease. Mov Disord (2009) 2.20
Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry (2001) 1.21
Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol (2005) 1.14
Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 1.13
Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry (2012) 0.98
Visual hallucinatory syndromes: past, present, and future. Dialogues Clin Neurosci (2007) 0.90
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurol (2009) 0.88
Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol (2005) 0.88
Neuropsychiatric non-motor aspects of Parkinson's disease. Postgrad Med J (2003) 0.87
An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother (2011) 0.85
Beyond tremor and rigidity: non-motor features of Parkinson's disease. J Neural Transm (Vienna) (2009) 0.85
Psychosis in Parkinson's disease. Postgrad Med J (2005) 0.84
Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study. PLoS One (2014) 0.81
Charles Bonnet syndrome: two case reports and review of the literature. J Neurol (2013) 0.80
Psychosis assessment in early-stage Parkinson's disease: comparing Parkinson's psychosis questionnaire with the brief psychiatric rating scale in a portuguese sample. Parkinsons Dis (2012) 0.78
Psychiatric symptoms screening in the early stages of Parkinson's disease. J Neurol (2011) 0.77
Neuropsychiatric co-morbidities in non-demented Parkinson's disease. Ann Indian Acad Neurol (2015) 0.76
Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol (2007) 0.76
A clinical profile of patients with Parkinson's disease and psychosis. Ann Indian Acad Neurol (2014) 0.76
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? NPJ Parkinsons Dis (2017) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Cornell Scale for Depression in Dementia. Biol Psychiatry (1988) 6.61
Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex (1978) 4.78
Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia (1990) 3.79
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl (1993) 2.27
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain (1991) 2.15
Visual hallucinations associated with Parkinson disease. Arch Neurol (1996) 2.06
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology (1996) 1.57
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology (1995) 1.57
Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry (1978) 1.17
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol (1982) 1.11
Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc (1991) 1.10
Parkinson's disease: drug-induced psychiatric states. Adv Neurol (1995) 1.05
The history of clozapine. Psychopharmacology (Berl) (1989) 1.00
Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry (1982) 0.98
Mental disorders in Parkinson's disease after treatment with L-DOPA. Adv Neurol (1984) 0.87
Hallucinations in Parkinson disease: neuropsychological study. Ital J Neurol Sci (1990) 0.84
Serotonin reuptake inhibitors, paranoia, and the ventral basal ganglia. Clin Neuropharmacol (1991) 0.82
Mental disorders in Parkinson's disease. J Neural Transm Suppl (1992) 0.79
Dopaminergic psychosis in advanced Parkinson's disease. Adv Neurol (1990) 0.79
The humoral response in the pathogenesis of gluten ataxia. Neurology (2002) 2.84
Panayiotopoulos syndrome: a common and benign childhood epilepsy. Lancet (2001) 2.80
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain (1991) 2.15
Levodopa in pregnancy. Mov Disord (1995) 2.06
Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology (1993) 2.04
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet (1998) 1.83
Sensory ganglionopathy due to gluten sensitivity. Neurology (2010) 1.57
Insidious endocarditis caused by Chlamydia psittaci. Br Med J (1975) 1.45
Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry (1982) 1.45
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain (2000) 1.45
Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry (2002) 1.42
Isolated inferior sagittal sinus thrombosis: a case report. Neuroradiology (1997) 1.39
Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry (2003) 1.38
Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology (2006) 1.34
Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology (2001) 1.26
Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy. Epilepsia (1994) 1.25
Seizure characteristics, pathology, and outcome after temporal lobectomy. Neurology (1987) 1.19
Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry (2006) 1.16
A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord (1999) 1.15
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain (1992) 1.13
Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol (1993) 1.12
Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology (1995) 1.12
Idiopathic focal dystonia: a disorder of muscle spindle afferent processing? Brain (1997) 1.09
Abnormal perception of vibration-induced illusion of movement in dystonia. Neurology (1999) 1.08
Cognitive outcome after aneurysm rupture: relationship to aneurysm site and perioperative complications. Neurology (1995) 1.05
Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry (1997) 1.04
The effect of fatigue on abnormal vibration induced illusion of movement in idiopathic focal dystonia. J Neurol Neurosurg Psychiatry (2003) 1.03
Linear sweep voltammetry with carbon paste electrodes in the rat striatum. Neuroscience (1982) 1.00
Medical errors. Different formulations of drugs often look confusingly similar. BMJ (2001) 0.98
Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease. Brain (1994) 0.97
Nevus of Ota associated with meningeal melanosis and intracranial melanoma. Case report. J Neurosurg (1983) 0.96
Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology (2013) 0.94
A component analysis of the generation and release of isometric force in Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 0.94
Subacute sensory neuropathy with remission: an association with lymphoma. J Neurol Neurosurg Psychiatry (1982) 0.91
A deficit profile of executive, memory, and motor functions in schizophrenia. Biol Psychiatry (1994) 0.90
A non-cholinergic function for acetylcholinesterase in the substantia nigra: behavioural evidence. Exp Brain Res (1984) 0.90
Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry (2005) 0.90
Cognitive components of reaction time in Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 0.90
Dissociations among processes in remote memory. Ann N Y Acad Sci (1985) 0.89
Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology (2001) 0.89
Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment. Brain (1993) 0.88
IgG synthesis within the central nervous system. Comparison of three formulas. Arch Neurol (1987) 0.88
Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry (2005) 0.87
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. Clin Neuropharmacol (1998) 0.87
Idiopathic generalised epilepsy: a pilot study of memory and neuronal dysfunction in the temporal lobes, assessed by magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatry (2006) 0.87
Abnormal perception of the tonic vibration reflex in idiopathic focal dystonia. Eur J Neurol (2000) 0.86
Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway. J Comp Neurol (1983) 0.86
Double dissociation of short-term and long-term memory for nonverbal material in Parkinson's disease and global amnesia. A further analysis. Brain (1991) 0.85
Slowing of reaction time in Parkinson's disease: the involvement of the frontal lobes. Neuropsychologia (1999) 0.85
Patterns of content, contextual, and working memory impairments in schizophrenia and nonamnesic alcoholism. Neuropsychology (1997) 0.85
Nonverbal recognition and recency discrimination deficits in Parkinson's disease and Alzheimer's disease. Brain (1989) 0.85
GAD antibody-associated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand (2011) 0.84
Accelerated long-term forgetting in temporal lobe but not idiopathic generalised epilepsy. Neuropsychologia (2011) 0.83
The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci (1991) 0.83
Video game induced seizures. J Neurol Neurosurg Psychiatry (1994) 0.83
MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias. Acta Neurol Scand (2011) 0.83
Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. J Clin Exp Neuropsychol (1989) 0.82
Local synthesis of CSF immunoglobulins. A neuroimmunological classification. J Neurol Sci (1981) 0.82
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Neuropsychologia (1993) 0.82
Subcortical hypoperfusion following surgery for aneurysmal subarachnoid haemorrhage: implications for cognitive performance? Behav Neurol (2000) 0.82
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics (2000) 0.82
Clinical and immunological associations in myasthenia gravis. 1: Autoantibodies. J Neurol Neurosurg Psychiatry (1980) 0.82
Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note. J Neurol Neurosurg Psychiatry (1998) 0.81
Encoding ability is preserved in amnesia: evidence from a direct test of encoding. Neuropsychologia (1993) 0.81
Lymphocyte subpopulations in multiple sclerosis: serial studies and clinical correlations. J Neurol Sci (1979) 0.80
Gluten sensitivity: a many headed hydra. BMJ (1999) 0.80
The role of the striatum in motor learning: dissociations between isometric motor control processes in Parkinson's disease. Int J Neurosci (1994) 0.79
Voltammetric carbon paste electrodes monitor uric acid and not 5-HIAA at the 5-hydroxyindole potential in the rat brain. Neurosci Lett (1984) 0.79
Late onset radiation-induced motor neuron syndrome. J Neurol Neurosurg Psychiatry (1992) 0.78
Behçet's syndrome: unusual multisystem involvement and immune complexes. Postgrad Med J (1980) 0.78
Cell-mediated immunity to viral antigens and tuberculin in multiple sclerosis. Acta Neurol Scand (1981) 0.78
Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity. J Neurol Neurosurg Psychiatry (1980) 0.78
Central nervous system IgG synthesis in multiple sclerosis. Application of a new formula. Acta Neurol Scand (1983) 0.77
Cell-mediated immunity in acute idiopathic optic neuritis and multiple sclerosis. Acta Neurol Scand (1981) 0.77
Abnormal vibration induced illusion of movement in essential tremor: evidence for abnormal muscle spindle afferent function. J Neurol Neurosurg Psychiatry (2005) 0.77
Parkinson's disease and CYP1A2 activity. Br J Clin Pharmacol (2000) 0.77
Quantitative hippocampal MRI and intractable temporal lobe epilepsy. 1995. Neurology (2001) 0.77
Two tests for assessing remote public knowledge: a tool for assessing retrograde amnesia. Memory (1994) 0.76
Gluten sensitivity masquerading as systemic lupus erythematosus. Ann Rheum Dis (2004) 0.76
Progression of dystonia: learning from distorted feedback? J Neurol Neurosurg Psychiatry (2007) 0.75
Magnetic resonance imaging in epilepsy. Lancet (1992) 0.75
Abnormalities of central motor conduction in Parkinson's disease. J Neurol Sci (1990) 0.75
Herpes simplex type 2 meningitis treated with acyclovir. Postgrad Med J (1984) 0.75
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry (1999) 0.75
Editorial. Behav Neurol (1994) 0.75
Automatic registration of SPECT images as an alternative to immobilization in neuroactivation studies. Phys Med Biol (1995) 0.75
Book review. Behav Neurol (1996) 0.75
Stem-completion priming in Alzheimer's disease: the importance of target word articulation. Neuropsychologia (1996) 0.75
Encoding deficits in untreated Parkinson's disease. Cortex (1993) 0.75
Book review. Behav Neurol (1997) 0.75
Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience. Seizure (2002) 0.75
The relationship between hydramnios and some characteristics of the infant in pregnancies complicated by fetal anencephaly. J Obstet Gynaecol Br Commonw (1973) 0.75
A progressive parkinsonian syndrome developing after chemotherapy and radiotherapy for non-Hodgkin's lymphoma. Mov Disord (1994) 0.75
Book review. Behav Neurol (1995) 0.75
Audit of healthcare provision for UK prisoners with suspected epilepsy. Seizure (2007) 0.75
Quantitative MR relaxometry study of effects of vigabatrin on the brains of patients with epilepsy. Epilepsy Res (1994) 0.75